Nautilus Biotechnology, Inc.NAUTNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank57
3Y CAGR+0.1%
5Y CAGR+35.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+0.1%/yr
vs -14.3%/yr prior
5Y CAGR
+35.1%/yr
Recent deceleration
Acceleration
+14.4pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
4.5x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $60.37M | -19.6% |
| 2024 | $75.12M | +6.6% |
| 2023 | $70.45M | +17.0% |
| 2022 | $60.20M | +26.3% |
| 2021 | $47.66M | +255.7% |
| 2020 | $13.40M | +32.5% |
| 2019 | $10.11M | -90.9% |
| 2018 | $111.68M | - |